High altitude cerebral edema and acute mountain sickness: A pathophysiology update

Advances in Experimental Medicine and Biology

Volumn 474, Issue , 2000, Pages 23-45

  Hackett, P H ^a  

^a St Mary's Hospital Grand Junction   (United States)

Author keywords

Altitude illness; Blood brain barrier; Cerebrospinal fluid; Cytotoxic edema; ICP; Intracranial dynamics; Intracranial pressure; Pathophysiology; Vasogenic edema

Indexed keywords

ACETAZOLAMIDE; FUROSEMIDE; GLYCEROL; MANNITOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UREA; VASCULOTROPIN;

ALTITUDE DISEASE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN OXYGEN CONSUMPTION; CAPILLARY PRESSURE; CARDIOVASCULAR AUTOREGULATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIURETIC THERAPY; FLUID BALANCE; HUMAN; HYPOXIA; INTRACRANIAL PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN THERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ALTITUDE; ALTITUDE SICKNESS; BRAIN; BRAIN EDEMA; CEREBROVASCULAR CIRCULATION; HEMODYNAMIC PROCESSES; HUMANS;

EID: 0034464601     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (54)

1. Control of brain endothelial permeability
2. Effects of hypoxia on the activity of the dopaminergic neuron system in the rat striatum as studied by in vivo brain microdialysis
3. Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans
4. Can excessive iNOS induction explain much of the illness of acute mountain sickness?
5. Hormonal control of fluid and electrolyte balance at high altitude in normal subjects
6. Body fluids, body composition, and metabolic aspects of high-altitude adaptation
7. Benzedrine sulphate (amphetamine) and acute anoxia. I. respiratory effects
8. Brain dysfunction in mild to moderate hypoxia
9. Down-regulation in muscle Na-K ATPase concentration following a 21 day expedition to 6200 m
10. The effects of changes in PaCO2 on cerebral blood volume, blood flow, and vascular mean transit time
11. Influence of hypoxia on the composition of isolated edema fluid in cold-induced brain edema
12. Cerebral blood velocity and cerebral spinal fluid pressure in acute mountain sickness
13. Acute mountain sickness and the edemas of high altitude: A common pathogenesis?
14. The incidence, importance, and prophylaxis of acute mountain sickness
15. High-altitude medicine
16. High altitude cerebral edema evaluated with magnetic resonance imaging: Clinical correlation and pathophysiology
17. Effects of acute high altitude exposure on body fluids
18. A hypothesis regarding the pathophysiology of acute mountain sickness
19. Cerebral spinal fluid pressure and cerebral blood velocity in acute mountain sickness
20. Electrolytes, body fluid volumes and renal function in acute hypoxic hypoxia
21. Cerebral form of high altitude illness
22. Cranial CSF volume (cCSF) is reduced by altitude exposure but is not related to early acute mountain sickness (AMS)
23. Corpus callosum (CC) MRI: Early altitude exposure
24. Pathophysiologic aspects of brain edema
25. Presidential address: Neuropathologic aspects of brain edema
26. Clinical features of patients with high altitude pulmonary edema in Japan
27. Cerebral hemodynamics and high altitude cerebral edema
28. A neurogenic basis for acute altitude illness
29. High altitude cerebral edema: An animal model
30. The brain: Cerebral blood flow
31. High-altitude cerebral oedema
32. Dynamic cerebral autoregulation at high altitude
33. Dexamethasone in the treatment of acute mountain sickness
34. Cerebral edema in acute mountain sickness
35. Role of veins and cerebral venous pressure in disruption of the blood-brain barrier
36. Volume and pressure in the craniospinal axis
37. Effect of altitude exposure on brain volume and development of acute mountain sickness (AMS)
38. The sagittal diameter of the spinal cord and subarachnoid space in different age groups: A roentgenographic post-mortem study
39. Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels
40. Central noradrenergic regulation of cerebral blood flow and vascular permeability
41. Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia
42. Raised intracranial pressure in neurologic disease
43. The random nature of cerebral mountain sickness
44. Mediators of vasogenic edema
45. Brain edema: Pathogenesis and therapy
46. Cerebral circulation at altitude
47. Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema
48. Characterization of clinical CSF dynamics and neural axis compliance using the pressure-volume index. I: The normal pressure-volume index
49. Acute mountain sickness
50. Pathophysiology of acute mountain sickness and high altitude pulmonary oedema: An hypothesis
51. High altitude pulmonary edema is caused by stress failure of pulmonary capillaries
52. Intracranial pressure at high altitude and acute mountain sickness
53. Cerebral blood flow and metabolic responses to sustained hypercapnia in awake sheep
54. Cerebral etiology of acute mountain sickness MRI findings